Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q5297311> ?p ?o }
Showing triples 1 to 39 of
39
with 100 triples per page.
- Q5297311 subject Q52364.
- Q5297311 subject Q7068907.
- Q5297311 subject Q8298466.
- Q5297311 subject Q8388296.
- Q5297311 abstract "Dopexamine is a synthetic analogue of dopamine. Despite this, it is a β1 and β2-adrenergic receptor agonist. Its action at dopamine receptor D1 mediates relaxation of vascular smooth muscle in renal, mesenteric, cerebral and coronary arteries. Mild action at D2 receptors decreases noradrenaline release.Use in sepsis has been proposed.It is used as an inotropic agent in cardiac failure. Side effects include arrhythmia, tremor, angina and flushing.".
- Q5297311 atcPrefix "C01".
- Q5297311 atcSuffix "CA14".
- Q5297311 casNumber "86197-47-9".
- Q5297311 fdaUniiCode "398E7Z7JB5".
- Q5297311 iupacName "4-[2-({6-[(2-phenylethyl)amino]hexyl}amino)ethyl]benzene-1,2-diol".
- Q5297311 pubchem "55483".
- Q5297311 thumbnail Dopexamine.png?width=300.
- Q5297311 wikiPageWikiLink Q183134.
- Q5297311 wikiPageWikiLink Q357415.
- Q5297311 wikiPageWikiLink Q407411.
- Q5297311 wikiPageWikiLink Q407684.
- Q5297311 wikiPageWikiLink Q415496.
- Q5297311 wikiPageWikiLink Q418617.
- Q5297311 wikiPageWikiLink Q423482.
- Q5297311 wikiPageWikiLink Q4897234.
- Q5297311 wikiPageWikiLink Q52364.
- Q5297311 wikiPageWikiLink Q575278.
- Q5297311 wikiPageWikiLink Q7068907.
- Q5297311 wikiPageWikiLink Q8298466.
- Q5297311 wikiPageWikiLink Q8388296.
- Q5297311 atcPrefix "1.0".
- Q5297311 atcSuffix "CA14".
- Q5297311 casNumber "86197".
- Q5297311 iupacName "4".
- Q5297311 pubchem "55483".
- Q5297311 unii "3980000000".
- Q5297311 type ChemicalSubstance.
- Q5297311 type Drug.
- Q5297311 type ChemicalObject.
- Q5297311 type Thing.
- Q5297311 type Q8386.
- Q5297311 comment "Dopexamine is a synthetic analogue of dopamine. Despite this, it is a β1 and β2-adrenergic receptor agonist. Its action at dopamine receptor D1 mediates relaxation of vascular smooth muscle in renal, mesenteric, cerebral and coronary arteries. Mild action at D2 receptors decreases noradrenaline release.Use in sepsis has been proposed.It is used as an inotropic agent in cardiac failure. Side effects include arrhythmia, tremor, angina and flushing.".
- Q5297311 label "Dopexamine".
- Q5297311 depiction Dopexamine.png.